Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Overview of attention for article published in Breast Cancer Research, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Preprint in Research Square (April 2024)

Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance

Article in Journal of Molecular Structure (April 2024)

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer

Article in JAMA Oncology (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.